inclusion criteria: * team member at hackensack meridian health * age: 18+ * willing to provide informed consent * formal diagnosis of covid-19 via polymerase chain reaction (pcr)test (if home test was done, team member must confirm via pcr test) * outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case) * must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) * symptom(s) have persisted for more than 12 weeks after initial infection * symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection * does not have soy allergy * does not have allergy to fish * able to participate in bi-weekly surveys in research electronic data capture (redcap) * able to take own blood pressure and record it in bi-weekly redcap survey * willing to participate in 12-week study and be assigned to either intervention or placebo arm * not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 iu) with potential for aiding recovery of long covid syndrome (e.g. zinc, vit c, elderberry). * able to take/swallow six mini-pills daily * able and willing to give a spot blood sample (2 drops) at baseline and end of study.

inclusion criteria: * team member at hackensack meridian health * age: 18+ * willing to provide informed consent * formal diagnosis of covid-19 via polymerase chain reaction (pcr)test (if home test was done, team member must confirm via pcr test) * outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case) * must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) * symptom(s) have persisted for more than 12 weeks after initial infection * symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection * does not have soy allergy * does not have allergy to fish * able to participate in bi-weekly surveys in research electronic data capture (redcap) * able to take own blood pressure and record it in bi-weekly redcap survey * willing to participate in 12-week study and be assigned to either intervention or placebo arm * not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 iu) with potential for aiding recovery of long covid syndrome (e.g. zinc, vit c, elderberry). * able to take/swallow six mini-pills daily * able and willing to give a spot blood sample (2 drops) at baseline and end of study.

inclusion criteria: team member at hackensack meridian health age: 18+ willing to provide informed consent formal diagnosis of covid-19 via polymerase chain reaction (pcr)test (if home test was done, team member must confirm via pcr test) outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case) must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) symptom(s) have persisted for more than 12 weeks after initial infection symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection does not have soy allergy does not have allergy to fish able to participate in bi-weekly surveys in research electronic data capture (redcap) able to take own blood pressure and record it in bi-weekly redcap survey willing to participate in 12-week study and be assigned to either intervention or placebo arm not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 iu) with potential for aiding recovery of long covid syndrome (e.g. zinc, vit c, elderberry). able to take/swallow six mini-pills daily able and willing to give a spot blood sample (2 drops) at baseline and end of study.

inclusion criteria: team member at hackensack meridian health age: 18+ willing to provide informed consent formal diagnosis of covid-19 via polymerase chain reaction (pcr)test (if home test was done, team member must confirm via pcr test) outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case) must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell) symptom(s) have persisted for more than 12 weeks after initial infection symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection does not have soy allergy does not have allergy to fish able to participate in bi-weekly surveys in research electronic data capture (redcap) able to take own blood pressure and record it in bi-weekly redcap survey willing to participate in 12-week study and be assigned to either intervention or placebo arm not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 iu) with potential for aiding recovery of long covid syndrome (e.g. zinc, vit c, elderberry). able to take/swallow six mini-pills daily able and willing to give a spot blood sample (2 drops) at baseline and end of study.